novel therapies and pitfalls in mpns
Published 4 years ago • 58 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
4:16
novel therapies for mpns
-
1:11
incorporating novel therapies into frontline all treatment
-
2:43
novel therapies in the future of mds treatment
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
1:06:04
itp: novel treatments
-
3:58
my story: niharika from india shares her struggle with the incurable itp
-
34:54
ask the mpn expert - dr. pemmaraju
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:41
novel therapies for high-risk mds
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
2:25
analyzing aml: novel therapies in review
-
2:54
novel therapies in aml and mds
-
1:33
what to look for in novel cll therapies
-
0:57
novel therapeutic strategies in all
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:11
exciting updates in all and the value of novel immunotherapies
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp